Merit Medical raises 2026 non-GAAP EPS guidance to $4.33-$4.37
MMSI•Merit Medical raised its 2026 non-GAAP EPS guidance to $4.33-$4.37 from $4.25-$4.35, with projected revenue growth of 7.9%-8.4%. Third-quarter revenue rose 8.4% to $416.2 million, and non-GAAP EPS increased 21.7% to $1.12.
1. Raised 2026 guidance
Merit Medical raised its 2026 non-GAAP earnings forecast to $4.33-$4.37 per share from $4.25-$4.35. It now projects revenue growth of 7.9%-8.4%, compared with its prior forecast of 7.6%-8.4%.
2. Third-quarter results
Third-quarter revenue rose 8.4% to $416.2 million, while non-GAAP earnings per share increased 21.7% to $1.12.
